Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2021, Vol. 12 Issue (1) : 297-307     DOI: 10.14336/AD.2020.0519
Review |
Melatonin: Effects on Cartilage Homeostasis and Therapeutic Prospects in Cartilage-related Diseases
Wen-qing Xie1,6, Song-feng Chen2, Xiao-hua Tao3, Li-yang Zhang4, Pei-wu Hu5, Wei-li Pan3, Yi-bin Fan3,*, Yu-sheng Li1,6,*
1Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China.
2Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan, China.
3Department of Dermatology, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, China.
4Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China.
5Department of Scientific Research, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China.
6National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China
Download: PDF(627 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Cartilage is a relatively simple connective tissue that plays a variety of roles in the human body, including joint support and protection, load bearing of the intervertebral discs, joint lubrication, formation of the external structure of the ears and nose and support of the trachea. The maintenance of cartilage homeostasis is therefore crucial. Cartilage-related diseases are difficult to diagnose and treat because their molecular and pathological mechanisms are not fully understood. Melatonin, which has a wide range of physiological effects, is an endocrine hormone mainly secreted by the pineal gland. Its biological effects include its antioxidant, antiaging, analgesic, and hypnotic effects and its ability to stabilize the circadian rhythm. In recent years, research on cartilage homeostasis and melatonin has been increasing, and melatonin has gradually been used in the treatment of cartilage-related diseases. Therefore, this article will briefly review the role of melatonin in cartilage homeostasis, including its anti-inflammatory effects and effects in protecting cartilage from damage by other factors and promoting chondrocyte growth and the expression of cartilage-related genes. Based on the above, the current status and future developmental direction of melatonin in the treatment of cartilage-related diseases are also discussed, demonstrating the broad prospects of melatonin in maintaining cartilage homeostasis and treating cartilage injury-related diseases.

Keywords melatonin      cartilage      cartilage homeostasis      inflammation      cartilage-related genes      human mesenchymal stromal cells     
Corresponding Authors: Fan Yi-bin,Li Yu-sheng   
About author:

These authors equally contributed this work.

Just Accepted Date: 20 May 2020   Issue Date: 11 January 2021
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Xie Wen-qing
Chen Song-feng
Tao Xiao-hua
Zhang Li-yang
Hu Pei-wu
Pan Wei-li
Fan Yi-bin
Li Yu-sheng
Cite this article:   
Xie Wen-qing,Chen Song-feng,Tao Xiao-hua, et al. Melatonin: Effects on Cartilage Homeostasis and Therapeutic Prospects in Cartilage-related Diseases[J]. Aging and disease, 2021, 12(1): 297-307.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2020.0519     OR
Figure 1.  The melatonin signaling pathway in the occurrence and development of OA.
Cartilage-related diseaseFunction of melatoninReferences
OAReducing inflammation, maintaining metabolic balance and reducing apoptosis[67, 69, 77]
Maintaining the survival of MSCs and promoting their osteogenic differentiation[91]
Rotator cuff repairInhibiting macrophage infiltration at the tendon-bone interface and increasing the formation of cartilage regions[94]
Cartilage tissue engineeringHydrogels or hydrogel/microparticle systems,
cartilage regeneration
[95,96,97]
Table 1  The functions of melatonin in cartilage-related diseases.
[1] Jiang Y, Tuan RS (2015). Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat Rev Rheumatol, 11:206-212.
[2] Miramini S, Smith DW, Zhang L, Gardiner BS (2017). The spatio-temporal mechanical environment of healthy and injured human cartilage during sustained activity and its role in cartilage damage. J Mech Behav Biomed Mater, 74:1-10.
[3] Bairati A, Comazzi M, Gioria M (1996). A comparative study of perichondrial tissue in mammalian cartilages. Tissue Cell, 28:455-468.
[4] Kobayashi S, Takebe T, Zheng YW, Mizuno M, Yabuki Y, Maegawa J, et al. (2011). Presence of cartilage stem/progenitor cells in adult mice auricular perichondrium. PLoS One, 6:e26393.
[5] Carballo CB, Nakagawa Y, Sekiya I, Rodeo SA (2017). Basic Science of Articular Cartilage. Clin Sports Med, 36:413-425.
[6] Simon TM, Jackson DW (2018). Articular Cartilage: Injury Pathways and Treatment Options. Sports Med Arthrosc Rev, 26:31-39.
[7] Rath B, Tingart M (2017). [Joint-specific procedures for hyaline cartilage repair]. Orthopade, 46:893.
[8] Richardson SM, Kalamegam G, Pushparaj PN, Matta C, Memic A, Khademhosseini A, et al. (2016). Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration. Methods, 99:69-80.
[9] Caldwell KL, Wang J (2015). Cell-based articular cartilage repair: the link between development and regeneration. Osteoarthritis Cartilage, 23:351-362.
[10] Castro-Vinuelas R, Sanjurjo-Rodriguez C, Pineiro-Ramil M, Hermida-Gomez T, Fuentes-Boquete IM, de Toro-Santos FJ, et al. (2018). Induced pluripotent stem cells for cartilage repair: current status and future perspectives. Eur Cell Mater, 36:96-109.
[11] Mizuno M, Takebe T, Kobayashi S, Kimura S, Masutani M, Lee S, et al. (2014). Elastic cartilage reconstruction by transplantation of cultured hyaline cartilage-derived chondrocytes. Transplant Proc, 46:1217-1221.
[12] Chen S, Fu P, Wu H, Pei M (2017). Meniscus, articular cartilage and nucleus pulposus: a comparative review of cartilage-like tissues in anatomy, development and function. Cell Tissue Res, 370:53-70.
[13] Fu S, Kuwahara M, Uchida Y, Koudo S, Hayashi D, Shimomura Y, et al. (2019). Circadian production of melatonin in cartilage modifies rhythmic gene expression. J Endocrinol
[14] Acuna-Castroviejo D, Escames G, Venegas C, Diaz-Casado ME, Lima-Cabello E, Lopez LC, et al. (2014). Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci, 71:2997-3025.
[15] Gossan N, Boot-Handford R, Meng QJ (2015). Ageing and osteoarthritis: a circadian rhythm connection. Biogerontology, 16:209-219.
[16] Jahanban-Esfahlan R, Mehrzadi S, Reiter RJ, Seidi K, Majidinia M, Baghi HB, et al. (2018). Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes. Br J Pharmacol, 175:3230-3238.
[17] Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM (1986). Human melatonin production decreases with age. J Pineal Res, 3:379-388.
[18] Alberti C (1958). [Melatonin: the first hormone isolated from the pineal body]. Farmaco Sci, 13:604-605.
[19] Cecon E, Liu L, Jockers R (2019). Melatonin receptor structures shed new light on melatonin research. J Pineal Res, 67:e12606.
[20] Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR (2011). Melatonin--a pleiotropic, orchestrating regulator molecule. Prog Neurobiol, 93:350-384.
[21] Bubenik GA, Niles LP, Pang SF, Pentney PJ (1993). Diurnal variation and binding characteristics of melatonin in the mouse brain and gastrointestinal tissues. Comp Biochem Physiol C, 104:221-224.
[22] Yin J, Li Y, Han H, Chen S, Gao J, Liu G, et al. (2018). Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice. J Pineal Res, 65:e12524.
[23] Amaral FGD, Cipolla-Neto J (2018). A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab, 62:472-479.
[24] Tan DX, Manchester LC, Esteban-Zubero E, Zhou Z, Reiter RJ (2015). Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism. Molecules, 20:18886-18906.
[25] Markus RP, Fernandes PA, Kinker GS, da Silveira Cruz-Machado S, Marcola M (2018). Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. Br J Pharmacol, 175:3239-3250.
[26] Golan K, Kumari A, Kollet O, Khatib-Massalha E, Subramaniam MD, Ferreira ZS, et al. (2018). Daily Onset of Light and Darkness Differentially Controls Hematopoietic Stem Cell Differentiation and Maintenance. Cell Stem Cell, 23:572-585 e577.
[27] Golan K, Kollet O, Markus RP, Lapidot T (2019). Daily light and darkness onset and circadian rhythms metabolically synchronize hematopoietic stem cell differentiation and maintenance: The role of bone marrow norepinephrine, tumor necrosis factor, and melatonin cycles. Exp Hematol, 78:1-10.
[28] Beriwal N, Namgyal T, Sangay P, Al Quraan AM (2019). Role of immune-pineal axis in neurodegenerative diseases, unraveling novel hybrid dark hormone therapies. Heliyon, 5:e01190.
[29] Markus RP, Cecon E, Pires-Lapa MA (2013). Immune-pineal axis: nuclear factor kappaB (NF-kB) mediates the shift in the melatonin source from pinealocytes to immune competent cells. Int J Mol Sci, 14:10979-10997.
[30] Slominski AT, Semak I, Fischer TW, Kim TK, Kleszczynski K, Hardeland R, et al. (2017). Metabolism of melatonin in the skin: Why is it important? Exp Dermatol, 26:563-568.
[31] Claustrat B, Leston J (2015). Melatonin: Physiological effects in humans. Neurochirurgie, 61:77-84.
[32] Majidinia M, Reiter RJ, Shakouri SK, Mohebbi I, Rastegar M, Kaviani M, et al. (2018). The multiple functions of melatonin in regenerative medicine. Ageing Res Rev, 45:33-52.
[33] Dubocovich ML (1995). Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci, 16:50-56.
[34] Morgan PJ, Barrett P, Howell HE, Helliwell R (1994). Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int, 24:101-146.
[35] Jockers R, Maurice P, Boutin JA, Delagrange P (2008). Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol, 154:1182-1195.
[36] Waly NE, Hallworth R (2015). Circadian Pattern of Melatonin MT1 and MT2 Receptor Localization in the Rat Suprachiasmatic Nucleus. J Circadian Rhythms, 13:1.
[37] Zlotos DP, Jockers R, Cecon E, Rivara S, Witt-Enderby PA (2014). MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential. J Med Chem, 57:3161-3185.
[38] Zawilska JB, Skene DJ, Arendt J (2009). Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep, 61:383-410.
[39] Dubocovich ML, Markowska M (2005). Functional MT1 and MT2 melatonin receptors in mammals. Endocrine, 27:101-110.
[40] Boutin JA (2016). Quinone reductase 2 as a promising target of melatonin therapeutic actions. Expert Opin Ther Targets, 20:303-317.
[41] Slominski AT, Kim TK, Takeda Y, Janjetovic Z, Brozyna AA, Skobowiat C, et al. (2014). RORalpha and ROR gamma are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. Faseb j, 28:2775-2789.
[42] Steinhilber D, Brungs M, Werz O, Wiesenberg I, Danielsson C, Kahlen JP, et al. (1995). The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem, 270:7037-7040.
[43] Slominski AT, Zmijewski MA, Jetten AM (2016). RORalpha is not a receptor for melatonin (response to DOI 10.1002/bies.201600018). Bioessays, 38:1193-1194.
[44] Galano A, Tan DX, Reiter RJ (2013). On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res, 54:245-257.
[45] Reiter RJ, Tan DX, Rosales-Corral S, Galano A, Zhou XJ, Xu B (2018). Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions. Molecules, 23.
[46] Carvalho-Sousa CE, Pereira EP, Kinker GS, Veras M, Ferreira ZS, Barbosa-Nunes FP, et al. (2020). Immune-pineal axis protects rat lungs exposed to polluted air. J Pineal Res, 68:e12636.
[47] Palukuru UP, McGoverin CM, Pleshko N (2014). Assessment of hyaline cartilage matrix composition using near infrared spectroscopy. Matrix Biol, 38:3-11.
[48] Li YJ, Zhao YH, Yang Q (2019). [Development of cartilage extracellular matrix in cartilage tissue engineering]. Hua Xi Kou Qiang Yi Xue Za Zhi, 37:220-223.
[49] Zhang Z (2015). Chondrons and the pericellular matrix of chondrocytes. Tissue Eng Part B Rev, 21:267-277.
[50] Brittberg M, Gomoll AH, Canseco JA, Far J, Lind M, Hui J (2016). Cartilage repair in the degenerative ageing knee. Acta Orthop, 87:26-38.
[51] Redondo ML, Beer AJ, Yanke AB (2018). Cartilage Restoration: Microfracture and Osteochondral Autograft Transplantation. J Knee Surg, 31:231-238.
[52] Wei Y, Bai L (2016). Recent advances in the understanding of molecular mechanisms of cartilage degeneration, synovitis and subchondral bone changes in osteoarthritis. Connect Tissue Res, 57:245-261.
[53] Yu D, Xu J, Liu F, Wang X, Mao Y, Zhu Z (2016). Subchondral bone changes and the impacts on joint pain and articular cartilage degeneration in osteoarthritis. Clin Exp Rheumatol, 34:929-934.
[54] Sandya S, Achan MA, Sudhakaran PR (2007). Parallel changes in fibronectin and alpha5beta1 integrin in articular cartilage in type II collagen-induced arthritis. Indian J Biochem Biophys, 44:14-18.
[55] Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B, et al. (2013). Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis Rheum, 65:981-992.
[56] Muntyanu A, Abji F, Liang K, Pollock RA, Chandran V, Gladman DD (2016). Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis. Arthritis Res Ther, 18:296.
[57] Scanzello CR (2017). Role of low-grade inflammation in osteoarthritis. Curr Opin Rheumatol, 29:79-85.
[58] Atukorala I, Kwoh CK, Guermazi A, Roemer FW, Boudreau RM, Hannon MJ, et al. (2016). Synovitis in knee osteoarthritis: a precursor of disease? Ann Rheum Dis, 75:390-395.
[59] Mathiessen A, Conaghan PG (2017). Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res Ther, 19:18.
[60] Roughley PJ (2001). Articular cartilage and changes in arthritis: noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage. Arthritis Res, 3:342-347.
[61] Yang G, Li S, Li B, Cheng L, Jiang P, Tian Z, et al. (2017). Protective Effects of Garlic-Derived S-Allylmercaptocysteine on IL-1beta-Stimulated Chondrocytes by Regulation of MMPs/TIMP-1 Ratio and Type II Collagen Expression via Suppression of NF-kappaB Pathway. Biomed Res Int, 2017:8686207.
[62] Tian J, Chen JW, Gao JS, Li L, Xie X (2013). Resveratrol inhibits TNF-alpha-induced IL-1beta, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. Rheumatol Int, 33:1829-1835.
[63] Radogna F, Diederich M, Ghibelli L (2010). Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol, 80:1844-1852.
[64] Hansson I, Holmdahl R, Mattsson R (1992). The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. J Neuroimmunol, 39:23-30.
[65] Cutolo M, Straub RH (2008). Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmun Rev, 7:223-228.
[66] Chen Q, Wei W (2002). Effects and mechanisms of melatonin on inflammatory and immune responses of adjuvant arthritis rat. Int Immunopharmacol, 2:1443-1449.
[67] Huang CC, Chiou CH, Liu SC, Hu SL, Su CM, Tsai CH, et al. (2019). Melatonin attenuates TNF-alpha and IL-1beta expression in synovial fibroblasts and diminishes cartilage degradation: Implications for the treatment of rheumatoid arthritis. J Pineal Res, 66:e12560.
[68] Gao B, Gao W, Wu Z, Zhou T, Qiu X, Wang X, et al. (2018). Melatonin rescued interleukin 1beta-impaired chondrogenesis of human mesenchymal stem cells. Stem Cell Res Ther, 9:162.
[69] Hosseinzadeh A, Kamrava SK, Joghataei MT, Darabi R, Shakeri-Zadeh A, Shahriari M, et al. (2016). Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin. J Pineal Res, 61:411-425.
[70] Lane NE, Shidara K, Wise BL (2017). Osteoarthritis year in review 2016: clinical. Osteoarthritis Cartilage, 25:209-215.
[71] Heldens GT, Blaney Davidson EN, Vitters EL, Schreurs BW, Piek E, van den Berg WB, et al. (2012). Catabolic factors and osteoarthritis-conditioned medium inhibit chondrogenesis of human mesenchymal stem cells. Tissue Eng Part A, 18:45-54.
[72] Henrotin Y, Kurz B, Aigner T (2005). Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage, 13:643-654.
[73] Yang W, Kang X, Liu J, Li H, Ma Z, Jin X, et al. (2016). Clock Gene Bmal1 Modulates Human Cartilage Gene Expression by Crosstalk With Sirt1. Endocrinology, 157:3096-3107.
[74] Galasso O, Familiari F, De Gori M, Gasparini G (2012). Recent findings on the role of gelatinases (matrix metalloproteinase-2 and -9) in osteoarthritis. Adv Orthop, 2012:834208.
[75] Guo JY, Li F, Wen YB, Cui HX, Guo ML, Zhang L, et al. (2017). Melatonin inhibits Sirt1-dependent NAMPT and NFAT5 signaling in chondrocytes to attenuate osteoarthritis. Oncotarget, 8:55967-55983.
[76] Sondergaard BC, Henriksen K, Wulf H, Oestergaard S, Schurigt U, Brauer R, et al. (2006). Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Cartilage, 14:738-748.
[77] Lim HD, Kim YS, Ko SH, Yoon IJ, Cho SG, Chun YH, et al. (2012). Cytoprotective and anti-inflammatory effects of melatonin in hydrogen peroxide-stimulated CHON-001 human chondrocyte cell line and rabbit model of osteoarthritis via the SIRT1 pathway. J Pineal Res, 53:225-237.
[78] Hartmann K, Koenen M, Schauer S, Wittig-Blaich S, Ahmad M, Baschant U, et al. (2016). Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy. Physiol Rev, 96:409-447.
[79] Nakamura M, Watanabe J, Ogawa R, Kanamura S (1997). Immunohistochemical localization of type II and type I collagens in articular cartilage of the femoral head of dexamethasone-treated rats. Histochem J, 29:645-654.
[80] Yang W, Kang X, Qin N, Li F, Jin X, Ma Z, et al. (2017). Melatonin protects chondrocytes from impairment induced by glucocorticoids via NAD(+)-dependent SIRT1. Steroids, 126:24-29.
[81] Wang FW, Wang Z, Zhang YM, Du ZX, Zhang XL, Liu Q, et al. (2013). Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxide-induced apoptosis in vitro. J Cell Biochem, 114:2346-2355.
[82] Zhang Z, Lin J, Tian N, Wu Y, Zhou Y, Wang C, et al. (2019). Melatonin protects vertebral endplate chondrocytes against apoptosis and calcification via the Sirt1-autophagy pathway. J Cell Mol Med, 23:177-193.
[83] Hong Y, Kim H, Lee S, Jin Y, Choi J, Lee SR, et al. (2017). Role of melatonin combined with exercise as a switch-like regulator for circadian behavior in advanced osteoarthritic knee. Oncotarget, 8:97633-97647.
[84] van der Pol CW, van Roovert-Reijrink IAM, Gussekloo SWS, Kranenbarg S, Leon-Kloosterziel KM, van Eijk-Priester MH, et al. (2019). Effects of lighting schedule during incubation of broiler chicken embryos on leg bone development at hatch and related physiological characteristics. PLoS One, 14:e0221083.
[85] Gao W, Lin M, Liang A, Zhang L, Chen C, Liang G, et al. (2014). Melatonin enhances chondrogenic differentiation of human mesenchymal stem cells. J Pineal Res, 56:62-70.
[86] Pei M, He F, Wei L, Rawson A (2009). Melatonin enhances cartilage matrix synthesis by porcine articular chondrocytes. J Pineal Res, 46:181-187.
[87] Liu X, Gong Y, Xiong K, Ye Y, Xiong Y, Zhuang Z, et al. (2013). Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells. J Pineal Res, 55:14-25.
[88] Liu X, Xu Y, Chen S, Tan Z, Xiong K, Li Y, et al. (2014). Rescue of proinflammatory cytokine-inhibited chondrogenesis by the antiarthritic effect of melatonin in synovium mesenchymal stem cells via suppression of reactive oxygen species and matrix metalloproteinases. Free Radic Biol Med, 68:234-246.
[89] Wu Z, Qiu X, Gao B, Lian C, Peng Y, Liang A, et al. (2018). Melatonin-mediated miR-526b-3p and miR-590-5p upregulation promotes chondrogenic differentiation of human mesenchymal stem cells. J Pineal Res, 65:e12483.
[90] Zhong ZM, Li T, Xu ZX, Meng TT, Zeng JH, Zheng S, et al. (2013). Effect of melatonin on the proliferation and differentiation of chondrocytes from rat vertebral body growth plate in vitro. Int J Med Sci, 10:1392-1398.
[91] Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J, et al. (2001). Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest, 107:35-44.
[92] Roos EM, Dahlberg L (2005). Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum, 52:3507-3514.
[93] Hong Y, Kim H, Lee Y, Lee S, Kim K, Jin Y, et al. (2014). Salutary effects of melatonin combined with treadmill exercise on cartilage damage. J Pineal Res, 57:53-66.
[94] Song W, Ma Z, Wang C, Li H, He Y (2019). Pro-chondrogenic and immunomodulatory melatonin-loaded electrospun membranes for tendon-to-bone healing. J Mater Chem B, 7:6564-6575.
[95] Naghizadeh Z, Karkhaneh A, Khojasteh A (2018). Simultaneous release of melatonin and methylprednisolone from an injectable in situ self-crosslinked hydrogel/microparticle system for cartilage tissue engineering. J Biomed Mater Res A, 106:1932-1940.
[96] Atoufi Z, Kamrava SK, Davachi SM, Hassanabadi M, Saeedi Garakani S, Alizadeh R, et al. (2019). Injectable PNIPAM/Hyaluronic acid hydrogels containing multipurpose modified particles for cartilage tissue engineering: Synthesis, characterization, drug release and cell culture study. Int J Biol Macromol, 139:1168-1181.
[97] Pescador D, Ibanez-Fonseca A, Sanchez-Guijo F, Brinon JG, Arias FJ, Muntion S, et al. (2017). Regeneration of hyaline cartilage promoted by xenogeneic mesenchymal stromal cells embedded within elastin-like recombinamer-based bioactive hydrogels. J Mater Sci Mater Med, 28:115.
[1] Yu Gao,Changhong Ren,Xiaohua Li,Wantong Yu,Sijie Li,Haiyan Li,Yan Wang,Dong Li,Ming Ren,Xunming Ji. Ischemic Conditioning Ameliorated Hypertension and Vascular Remodeling of Spontaneously Hypertensive Rat via Inflammatory Regulation[J]. Aging and disease, 2021, 12(1): 116-131.
[2] Huang Kuang,Zhi-Feng Zhou,Yu-Ge Zhu,Zhi-Kai Wan,Mei-Wen Yang,Fen-Fang Hong,Shu-Long Yang. Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective[J]. Aging and disease, 2021, 12(1): 308-326.
[3] Xingzhi Guo,Yanying Liu,David Morgan,Li-Ru Zhao. Reparative Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor in Aged APP/PS1 Mice[J]. Aging and disease, 2020, 11(6): 1423-1443.
[4] Yan Zhao,Jun-Kun Zhan,Youshuo Liu. A Perspective on Roles Played by Immunosenescence in the Pathobiology of Alzheimer's Disease[J]. Aging and disease, 2020, 11(6): 1594-1607.
[5] Senbo An,Huiyu Hu,Yusheng Li,Yihe Hu. Pyroptosis Plays a Role in Osteoarthritis[J]. Aging and disease, 2020, 11(5): 1146-1157.
[6] Ni Zeng,Zhi-Peng Yan,Xin-Yuan Chen,Guo-Xin Ni. Infrapatellar Fat Pad and Knee Osteoarthritis[J]. Aging and disease, 2020, 11(5): 1317-1328.
[7] Jiacheng Huang,Guoqiang Yang,Xiaoyi Xiong,Maolin Wang,Junjie Yuan,Qin Zhang,Changxiong Gong,Zhongming Qiu,Zhaoyou Meng,Rui Xu,Qiong Chen,Ru Chen,Lexing Xie,Qi Xie,Wenjie Zi,Guohui Jiang,Yu Zhou,Qingwu Yang. Age-related CCL12 Aggravates Intracerebral Hemorrhage-induced Brain Injury via Recruitment of Macrophages and T Lymphocytes[J]. Aging and disease, 2020, 11(5): 1103-1115.
[8] Li Tan,Thomas C Register,Raghunatha R Yammani. Age-Related Decline in Expression of Molecular Chaperones Induces Endoplasmic Reticulum Stress and Chondrocyte Apoptosis in Articular Cartilage[J]. Aging and disease, 2020, 11(5): 1091-1102.
[9] Dengyang Han,Zhengqian Li,Taotao Liu,Ning Yang,Yue Li,Jindan He,Min Qian,Zhongshen Kuang,Wen Zhang,Cheng Ni,Xiangyang Guo. Prebiotics Regulation of Intestinal Microbiota Attenuates Cognitive Dysfunction Induced by Surgery Stimulation in APP/PS1 Mice[J]. Aging and disease, 2020, 11(5): 1029-1045.
[10] Chi Him Poon,Yingyi Wang,Man-Lung Fung,Chengfei Zhang,Lee Wei Lim. Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications[J]. Aging and disease, 2020, 11(5): 1235-1259.
[11] Alan R Hipkiss. COVID-19 and Senotherapeutics: Any Role for the Naturally-occurring Dipeptide Carnosine?[J]. Aging and disease, 2020, 11(4): 737-741.
[12] Undurti N Das. Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19[J]. Aging and disease, 2020, 11(4): 746-755.
[13] Seong Gak Jeon, Anji Yoo, Dong Wook Chun, Sang Bum Hong, Hyunju Chung, Jin-il Kim, Minho Moon. The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis[J]. Aging and disease, 2020, 11(3): 705-724.
[14] Xiaoheng Li, Yajin Liao, Yuan Dong, Shuoshuo Li, Fengchao Wang, Rong Wu, Zengqiang Yuan, Jinbo Cheng. Mib2 Deficiency Inhibits Microglial Activation and Alleviates Ischemia-Induced Brain Injury[J]. Aging and disease, 2020, 11(3): 523-535.
[15] Pedro C Lara, Nam P Nguyen, David Macias-Verde, Javier Burgos-Burgos, Meritxell Arenas, Alice Zamagni, Vincent Vinh-Hung, Brigitta G Baumert, Micaela Motta, Arthur Sun Myint, Marta Bonet, Tiberiu Popescu, Te Vuong, Gokula Kumar Appalanaido, Lurdes Trigo, Ulf Karlsson, Juliette Thariat. Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease? Recommendation of the International Geriatric Radiotherapy Group[J]. Aging and disease, 2020, 11(3): 489-493.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd